The new hub will act as a central point of connection and engagement for the rar...
The Opdivo/Yervoy combination demonstrated statistically and clinically signific...
The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrep...
Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for...
Exscientia paid $20m in upfront cash and equity to buy its development partner G...
New global projections and advances in HIV therapies are also on the agenda at t...
Rona Therapeutics has secured $35m in its Series A+ financing round to advance i...
Meitheal Pharmaceuticals has gained rights to CONTEPO (fosfomycin for injection)...
The EMA has accepted the MAA of Deciphera Pharmaceuticals' vimseltinib to treat ...
Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and ...
Gene therapy trials can often be held back by cost and complexity. New database ...
Biomanufacturers must tread carefully when seeking the optimum solution for thei...
AbbVie has maintained a strong position within the immunology space for the past...
The new funding is set to fund the expansion of the company’s Phase IIb studies ...
The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart ...
In January, the US House Select Committee on the Strategic Competition between t...
